Allarity Therapeutics, Inc. (ALLR)

Allarity Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	0.17	2.03	19.56	0.3	1.52
Short-Term Investments	0	0	0.35	0	0
Cash & Cash Equivalents	0.17	2.03	19.91	0.3	1.52
Cash Growth	-91.82%	-89.81%	6579.53%	-80.45%	-
Receivables	0	0	0	0	0.1
Other Current Assets	1.81	2.94	1.5	1.42	1.72
Total Current Assets	1.97	4.97	21.4	1.72	3.34
Property, Plant & Equipment	0.02	0.03	0.09	0.35	0.44
Long-Term Investments	0	0	0	0.85	0.14
Goodwill and Intangibles	9.87	9.55	28.14	30.49	27.69
Total Long-Term Assets	9.89	9.58	28.23	31.69	28.26
Total Assets	11.86	14.54	49.63	33.4	31.61
Accounts Payable	8.42	6.25	0.7	2.12	2.18
Current Debt	1.3	2.65	0.1	1.52	0.62
Other Current Liabilities	4.45	2.32	19.92	1.9	1.92
Total Current Liabilities	14.17	11.22	20.72	5.53	4.72
Long-Term Debt	0	1.08	0.99	1.15	0.34
Other Long-Term Liabilities	0.45	0.35	9.14	2.28	5.64
Total Long-Term Liabilities	0.45	1.43	10.13	3.43	5.99
Total Liabilities	14.61	12.65	30.85	8.96	10.7
Total Debt	1.3	3.74	1.09	2.67	0.96
Debt Growth	-65.19%	243.92%	-59.28%	176.95%	-
Retained Earnings	-94.45	-82.55	-66.49	-39.84	-32.37
Comprehensive Income	-0.41	-0.72	-0.6	1.38	-1.09
Shareholders' Equity	-2.75	-0.11	18.15	24.44	18.09
Net Cash / Debt	-1.13	-1.71	18.82	-2.37	0.56
Net Cash Per Share	-11.39	-5017.65	82903.08	-20247.86	12466.67
Working Capital	-12.2	-6.25	0.69	-3.82	-1.38
Book Value Per Share	-27.64	-332.11	79927.08	209598.71	399350.86

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).